Xynomic Pharmaceuticals

About:

Xynomic Pharmaceuticals, Inc. is a clinical stage oncology-focused biopharmaceutical company.

Website: http://xynomicpharma.com/en/506-11/

Top Investors: Puhua Capital, Northern Light Venture Capital, Prosperico Ventures, Hakim Unique Internet, Zhongshan Bison Healthcare Investment

Description:

Xynomic Pharma focuses on in-licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. The founding executives worked at leading multinational biopharmaceutical companies (Schering, Eli Lilly, Merck, and Roche) in R&D roles. The founders also had successful entrepreneurial experiences including founding, building, and exiting successful US-China biopharmaceutical companies.Xynomic Pharma aims to build a comprehensive clinical and pre-clinical stage oncology pipeline targeting cancers with high prevalence in China, US and rest of the world. Xynomic Pharma leverages global resources, enabling the company to develop drugs in a cost and time-efficient manner.